Ecolab Opens Bioprocessing Applications Lab in Dongtan, Korea
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 29 2026
0mins
Should l Buy ECL?
Ecolab Life Sciences announced the opening of a new Bioprocessing Applications Lab in Dongtan, Korea, its first bioprocessing facility in Asia. The new center further strengthens the company's global Life Sciences footprint and supports customers operating in one of the world's most advanced biopharmaceutical manufacturing markets. The Korea BPAL supports a full range of process development activities from early-stage testing through studies that replicate manufacturing at scale, building on Ecolab's established bioprocessing applications network in the United States and the United Kingdom. The facility enables hands-on collaboration with Ecolab's bioprocessing experts to help customers optimize purification processes, enhance cost and process efficiency, and advance programs toward commercial readiness.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ECL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ECL
Wall Street analysts forecast ECL stock price to rise
12 Analyst Rating
9 Buy
3 Hold
0 Sell
Strong Buy
Current: 256.550
Low
275.00
Averages
303.20
High
335.00
Current: 256.550
Low
275.00
Averages
303.20
High
335.00
About ECL
Ecolab Inc. is engaged in offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. The Company’s Global Industrial segment provides water treatment and process applications, and cleaning and sanitizing solutions primarily to large industrial customers within the manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. Its Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education and retail industries. Its Global Healthcare & Life Sciences segment provides specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries. Its Global Pest Elimination segment provides services designed to detect, prevent, and eliminate pests, such as rodents and insects.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Ecolab Declares Quarterly Cash Dividend
- Quarterly Cash Dividend: Ecolab's board declared a cash dividend of $0.73 per common share, payable on July 15, 2026, reflecting the company's ongoing financial health and commitment to shareholders.
- Dividend History: With 89 consecutive years of cash dividends, Ecolab demonstrates stable profitability and a strong focus on shareholder returns, which enhances investor confidence.
- Global Business Scale: Ecolab generates $16 billion in annual sales, employs 48,000 associates, and serves over 170 countries across 40 industries, underscoring its leadership in water, hygiene, and infection prevention solutions.
- Sustainability Goals: Ecolab aims to protect 2 billion people from infections and conserve drinking water for 1 billion people by 2030, showcasing its strategic vision for global health and environmental protection.
See More
Ecolab to Host Live Webcast of 2026 Annual Stockholders Meeting
- Meeting Time and Format: Ecolab will hold its 2026 Annual Stockholders Meeting on May 7, 2026, at 9:30 a.m. Central Time, as a virtual-only event lasting approximately 30 minutes, allowing global shareholders to participate easily.
- Participation Method: Shareholders must log in to www.virtualshareholdermeeting.com/ECL2026 using the 16-digit control number found on their proxy card to participate and ask questions, while guests without a control number can register for listen-only mode, ensuring broad access to information.
- Company Background: Ecolab is a global leader in water, hygiene, and infection prevention solutions, generating $16 billion in annual sales, employing 48,000 associates, and serving customers in over 170 countries and 40 industries, committed to protecting one-third of the world's food production and a quarter of power generation.
- Future Goals: Ecolab aims to help protect 2 billion people from infections and conserve enough drinking water for 1 billion people by 2030, demonstrating its long-term commitment to sustainability and enhancing business performance.
See More
Ecolab Reports Q1 Earnings in Line with Expectations
- Earnings Meet Expectations: Ecolab's Q1 adjusted earnings per share of $1.52, up 7.8% from $1.41 a year earlier, matched Wall Street estimates, demonstrating the company's ability to maintain stable profitability.
- Significant Revenue Growth: Q1 revenues rose 10% year-over-year to $4.07 billion, driven by strong value pricing, volume growth, and improved productivity, indicating the company's sustained competitiveness in the market.
- Strong Life Sciences Performance: Ecolab's life sciences sales increased 11% year-over-year, with bioprocessing sales more than doubling during the quarter, highlighting rapid growth potential in this sector and further solidifying the company's market position.
- Cost Management Strategy: The company implemented a global energy surcharge to mitigate rising fuel costs, anticipating high-single-digit percentage increases in commodity costs starting Q2, reflecting a proactive approach to cost control and profit stabilization.
See More
Ecolab Projects Q2 Adjusted Earnings Between $2.02 and $2.12
- Earnings Forecast: Ecolab reported in its Q1 results that it expects adjusted earnings for Q2 to range between $2.02 and $2.12 per share, indicating confidence in its profitability despite market challenges.
- Long-Term Outlook: Looking ahead to fiscal 2026, Ecolab continues to project adjusted earnings between $8.43 and $8.63 per share, excluding the impact of the pending CoolIT Systems acquisition, reflecting sustained optimism for future growth.
- Cost Management Strategy: Ecolab plans to quickly offset rising commodity costs through accelerating pricing, record new business wins, and improved productivity, a strategy that will help maintain its competitive edge in the market.
- Market Performance: In pre-market trading on Tuesday, Ecolab's stock was priced at $266.40 on the NYSE, down $1.62 or 0.61%, reflecting a cautious market reaction to its earnings report.
See More
Ecolab Q1 Earnings Beat Expectations with Strong Growth
- Significant Revenue Growth: Ecolab reported Q1 revenue of $4.07 billion, reflecting a 10% year-over-year increase that exceeded market expectations by $40 million, demonstrating strong performance in Life Sciences and Global High-Tech sectors, thereby solidifying its market position.
- Improved Profitability: The reported operating income margin stood at 15.3%, while the adjusted operating income margin increased by 70 basis points to 16.7%, indicating substantial progress in cost control and efficiency improvements, which enhances the sustainability of future profitability.
- Optimistic Future Outlook: Ecolab expects adjusted diluted EPS to range between $8.43 and $8.63 for 2026, representing a 12% to 15% increase, slightly above market consensus, reflecting the company's confidence in future growth prospects.
- Cost Pressure Mitigation: The company plans to quickly offset rising commodity costs through accelerated pricing, record new business wins, and improved productivity, ensuring continued profitability growth momentum into Q2.
See More
Ecolab Expected to Exceed Q1 Earnings Estimates
- Earnings Announcement Date: Ecolab (ECL) is set to announce its Q1 2023 earnings on April 28 before market open, with consensus EPS estimates at $1.70, reflecting a 13.3% year-over-year growth, indicating sustained profitability improvements.
- Revenue Growth Expectations: Analysts forecast Ecolab's Q1 revenue to reach $4.03 billion, representing an 8.9% year-over-year increase, which highlights the company's positive performance amid recovering market demand and sales growth.
- Historical Performance Review: Over the past two years, Ecolab has beaten EPS estimates 75% of the time and revenue estimates 63% of the time, showcasing its consistent performance and market confidence.
- Estimation Revision Dynamics: In the last three months, EPS estimates have seen 8 upward revisions and 7 downward revisions, while revenue estimates experienced 10 upward revisions and 3 downward revisions, indicating optimistic market expectations for Ecolab's future performance.
See More
Ecolab Declares Quarterly Cash Dividend
- Quarterly Cash Dividend: Ecolab's board declared a cash dividend of $0.73 per common share, payable on July 15, 2026, reflecting the company's ongoing financial health and commitment to shareholders.
- Dividend History: With 89 consecutive years of cash dividends, Ecolab demonstrates stable profitability and a strong focus on shareholder returns, which enhances investor confidence.
- Global Business Scale: Ecolab generates $16 billion in annual sales, employs 48,000 associates, and serves over 170 countries across 40 industries, underscoring its leadership in water, hygiene, and infection prevention solutions.
- Sustainability Goals: Ecolab aims to protect 2 billion people from infections and conserve drinking water for 1 billion people by 2030, showcasing its strategic vision for global health and environmental protection.
See More
Ecolab to Host Live Webcast of 2026 Annual Stockholders Meeting
- Meeting Time and Format: Ecolab will hold its 2026 Annual Stockholders Meeting on May 7, 2026, at 9:30 a.m. Central Time, as a virtual-only event lasting approximately 30 minutes, allowing global shareholders to participate easily.
- Participation Method: Shareholders must log in to www.virtualshareholdermeeting.com/ECL2026 using the 16-digit control number found on their proxy card to participate and ask questions, while guests without a control number can register for listen-only mode, ensuring broad access to information.
- Company Background: Ecolab is a global leader in water, hygiene, and infection prevention solutions, generating $16 billion in annual sales, employing 48,000 associates, and serving customers in over 170 countries and 40 industries, committed to protecting one-third of the world's food production and a quarter of power generation.
- Future Goals: Ecolab aims to help protect 2 billion people from infections and conserve enough drinking water for 1 billion people by 2030, demonstrating its long-term commitment to sustainability and enhancing business performance.
See More
Ecolab Reports Q1 Earnings in Line with Expectations
- Earnings Meet Expectations: Ecolab's Q1 adjusted earnings per share of $1.52, up 7.8% from $1.41 a year earlier, matched Wall Street estimates, demonstrating the company's ability to maintain stable profitability.
- Significant Revenue Growth: Q1 revenues rose 10% year-over-year to $4.07 billion, driven by strong value pricing, volume growth, and improved productivity, indicating the company's sustained competitiveness in the market.
- Strong Life Sciences Performance: Ecolab's life sciences sales increased 11% year-over-year, with bioprocessing sales more than doubling during the quarter, highlighting rapid growth potential in this sector and further solidifying the company's market position.
- Cost Management Strategy: The company implemented a global energy surcharge to mitigate rising fuel costs, anticipating high-single-digit percentage increases in commodity costs starting Q2, reflecting a proactive approach to cost control and profit stabilization.
See More
Ecolab Projects Q2 Adjusted Earnings Between $2.02 and $2.12
- Earnings Forecast: Ecolab reported in its Q1 results that it expects adjusted earnings for Q2 to range between $2.02 and $2.12 per share, indicating confidence in its profitability despite market challenges.
- Long-Term Outlook: Looking ahead to fiscal 2026, Ecolab continues to project adjusted earnings between $8.43 and $8.63 per share, excluding the impact of the pending CoolIT Systems acquisition, reflecting sustained optimism for future growth.
- Cost Management Strategy: Ecolab plans to quickly offset rising commodity costs through accelerating pricing, record new business wins, and improved productivity, a strategy that will help maintain its competitive edge in the market.
- Market Performance: In pre-market trading on Tuesday, Ecolab's stock was priced at $266.40 on the NYSE, down $1.62 or 0.61%, reflecting a cautious market reaction to its earnings report.
See More
Ecolab Q1 Earnings Beat Expectations with Strong Growth
- Significant Revenue Growth: Ecolab reported Q1 revenue of $4.07 billion, reflecting a 10% year-over-year increase that exceeded market expectations by $40 million, demonstrating strong performance in Life Sciences and Global High-Tech sectors, thereby solidifying its market position.
- Improved Profitability: The reported operating income margin stood at 15.3%, while the adjusted operating income margin increased by 70 basis points to 16.7%, indicating substantial progress in cost control and efficiency improvements, which enhances the sustainability of future profitability.
- Optimistic Future Outlook: Ecolab expects adjusted diluted EPS to range between $8.43 and $8.63 for 2026, representing a 12% to 15% increase, slightly above market consensus, reflecting the company's confidence in future growth prospects.
- Cost Pressure Mitigation: The company plans to quickly offset rising commodity costs through accelerated pricing, record new business wins, and improved productivity, ensuring continued profitability growth momentum into Q2.
See More
Ecolab Expected to Exceed Q1 Earnings Estimates
- Earnings Announcement Date: Ecolab (ECL) is set to announce its Q1 2023 earnings on April 28 before market open, with consensus EPS estimates at $1.70, reflecting a 13.3% year-over-year growth, indicating sustained profitability improvements.
- Revenue Growth Expectations: Analysts forecast Ecolab's Q1 revenue to reach $4.03 billion, representing an 8.9% year-over-year increase, which highlights the company's positive performance amid recovering market demand and sales growth.
- Historical Performance Review: Over the past two years, Ecolab has beaten EPS estimates 75% of the time and revenue estimates 63% of the time, showcasing its consistent performance and market confidence.
- Estimation Revision Dynamics: In the last three months, EPS estimates have seen 8 upward revisions and 7 downward revisions, while revenue estimates experienced 10 upward revisions and 3 downward revisions, indicating optimistic market expectations for Ecolab's future performance.
See More
